Adam Crystal insider trades

Open-market stock purchases and sales by Adam Crystal, President, R&D at Tango Therapeutics, Inc, from SEC Form 4 filings since Feb 11, 2021.

Recent trades

DateStockTradeValue
Jun 1, 2026TNGX Tango Therapeutics, IncSold$137K
Jun 1, 2026TNGX Tango Therapeutics, IncSold$481K
Jun 1, 2026TNGX Tango Therapeutics, IncBought (not open market)—
May 1, 2026TNGX Tango Therapeutics, IncSold$549K
May 1, 2026TNGX Tango Therapeutics, IncSold$24.2K
May 1, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Apr 15, 2026TNGX Tango Therapeutics, IncSold$962K
Apr 15, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Apr 1, 2026TNGX Tango Therapeutics, IncSold$572K
Apr 1, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Mar 25, 2026TNGX Tango Therapeutics, IncSold$241K
Mar 25, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Mar 5, 2026TNGX Tango Therapeutics, IncSold$304K
Feb 25, 2026TNGX Tango Therapeutics, IncSold$694K
Feb 3, 2026TNGX Tango Therapeutics, IncSold$224K
Feb 3, 2026TNGX Tango Therapeutics, IncSold$2.6K
Feb 2, 2026TNGX Tango Therapeutics, IncBought (not open market)—
Feb 2, 2026TNGX Tango Therapeutics, IncBought (not open market)—

Companies traded

  • TNGX Tango Therapeutics, Inc: 16 sales, last Jun 1, 2026
  • CCCC C4 Therapeutics, Inc: 10 sales, last Jan 30, 2023

Get free alerts when Adam Crystal files a new trade →